Syllabus · Current · V5 (2025) · Cardiovascular System

D7 · Cardiovascular Pharmacology

D7.i · Inotropes & Vasopressors

Official V5 objective
Understand the pharmacology of inotropes and vasopressors.
15 SAQ topics 22 SAQ appearances 14 VIVA stations

Written examination

SAQ history

22 appearances
Describe the pharmacology of adrenaline.
90%
Compare and contrast adrenaline and levosimendan
60%
Compare and contrast the pharmacology of adrenaline and milrinone using the following headings: a) mechanism of action (30% of marks), b) pharmacokinetics relevant to the metabolism and elimination of each drug (20% of marks) c) pharmacodynamics and adverse effects (50% of marks).
51.8%
Compare and contrast the pharmacology of adrenaline and milrinone.
45%
Compare and contrast the relevant pharmacology of intravenous adrenaline and vasopressin.
20%
Compare and contrast the mechanism of action, pharmacokinetics, pharmacodynamics, and adverse effects of digoxin and levosimendan.
Compare and contrast the pharmacology of dobutamine and levosimendan.
41%
Compare and contrast milrinone and dobutamine using the following headings: (a) Class and indications for use (20% of marks). (b) Mechanisms of action (20% of marks). (c) Pharmacodynamics and adverse effects (60% of marks).
66%
Compare and contrast the pharmacology of dobutamine and milrinone
56%
Compare and contrast the pharmacology of EPHEDRINE and METARAMINOL.
27%
List the properties of an ideal inotrope (50% of marks). How does adrenaline compare with respect to these ideal properties? (50% of marks).
98%
List the properties of the ideal inotrope (50% of marks). How does adrenaline compare with respect to these ideal properties? (50% of marks).
86.4%
Classify commonly used inotropic agents. (40% of marks) Outline four different mechanisms of action for inotropic agents. (60% of marks)
65%
Classify the commonly used inotropic agents and describe their mechanism of action.
60%
Classify the commonly used inotropic agents and list their mechanisms of action.
Outline the pharmacology of noradrenaline.
22%
Compare and contrast the pharmacology of noradrenaline and dobutamine.
84%
Metaraminol vs. Noradrenaline
1 exam appearance
Compare and contrast the pharmacology of metaraminol and noradrenaline.
71%
Noradrenaline vs Vasopressin
3 exam appearances
Compare and contrast the pharmacology of noradrenaline and vasopressin.
49%
Compare and contrast the pharmacology of Noradrenaline and Vasopressin
50%
Compare and contrast the pharmacology of noradrenaline and vasopressin.
a) Classify hypersensitivity reactions and provide a brief outline of the immunological mechanisms underlying each type (20% of marks). b) Explain the immunological basis of anaphylaxis (50% of marks). c) Outline the pharmacology of adrenaline relevant to its use in the management of anaphylaxis (30% of marks).
51%

Oral examination

VIVA history

14 stations

Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.